# A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

> **NCT07175285** · — · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 223 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **DRUG:** Current standard of care treatment options

## Key facts

- **NCT ID:** NCT07175285
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-08
- **Primary completion:** 2028-03-24
- **Final completion:** 2032-10-05
- **Target enrollment:** 223 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07175285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07175285, "A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT07175285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*